---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-22-000009"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:36:15.669018+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Context Therapeutics updates corporate presentation, no new figures disclosed

## Summary
- Filed an updated corporate presentation dated January 2022 under Item 8.01.
- Presentation titled 'Bringing Change for Female Cancers' but contains no disclosed financial or pipeline specifics.
- No material operational or financial updates beyond the filing itself.
- Ticker: CNTX; stock trades on Nasdaq.

## SEC filing metadata
- accession: 0001842952-22-000009
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/0001842952-22-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/cntx-20220110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-22-000009
- JSON: https://secwatch.observer/filing/0001842952-22-000009.json
- Plain text: https://secwatch.observer/filing/0001842952-22-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.